Sexually Transmitted Diseases (STDs) Drug Market Report

Global and Region Sexually Transmitted Diseases (STDs) Drug Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 29, 2022
  • PAGES：165
  • REPORT CODE：GMM893621
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Sexually Transmitted Diseases (STDs) Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Sexually Transmitted Diseases (STDs) Drugmarket, defines the market attractiveness level of Sexually Transmitted Diseases (STDs) Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Sexually Transmitted Diseases (STDs) Drug industry, describes the types of Sexually Transmitted Diseases (STDs) Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Sexually Transmitted Diseases (STDs) Drug market and the development prospects and opportunities of Sexually Transmitted Diseases (STDs) Drug industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Sexually Transmitted Diseases (STDs) Drug market in Chapter 13.

    By Player:

    • AbbVie, Inc

    • Bayer Healthcare

    • Merck & Co, Inc

    • Hoffmann La Roche

    • Gilead Sciences

    • Pfizer

    • GlaxoSmithKline Plc

    • Eli Lilly

    • Bristol-Myers Squibb

    • Johnson & Johnson

    By Type:

    • Chlamydia

    • Gonorrhea

    • Syphilis

    • Genital herpes

    • HPV

    • HIV / AIDS

    By End-User:

    • Hospital Pharmacies

    • Retail Pharmacies

    • Online Pharmacies

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Sexually Transmitted Diseases (STDs) Drug Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Sexually Transmitted Diseases (STDs) Drug Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Sexually Transmitted Diseases (STDs) Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Sexually Transmitted Diseases (STDs) Drug Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Sexually Transmitted Diseases (STDs) Drug Market Analysis and Outlook to 2022

    • 7.1 Global Sexually Transmitted Diseases (STDs) Drug Consumption (2017-2022)

    • 7.2 United States Sexually Transmitted Diseases (STDs) Drug Consumption (2017-2022)

    • 7.3 Europe Sexually Transmitted Diseases (STDs) Drug Consumption (2017-2022)

    • 7.4 China Sexually Transmitted Diseases (STDs) Drug Consumption (2017-2022)

    • 7.5 Japan Sexually Transmitted Diseases (STDs) Drug Consumption (2017-2022)

    • 7.6 India Sexually Transmitted Diseases (STDs) Drug Consumption (2017-2022)

    • 7.7 South Korea Sexually Transmitted Diseases (STDs) Drug Consumption (2017-2022)

    8 Region and Country-wise Sexually Transmitted Diseases (STDs) Drug Market Analysis and Outlook to 2028

    • 8.1 Global Sexually Transmitted Diseases (STDs) Drug Consumption Forecast (2022-2028)

    • 8.2 United States Sexually Transmitted Diseases (STDs) Drug Consumption Forecast (2022-2028)

    • 8.3 Europe Sexually Transmitted Diseases (STDs) Drug Consumption Forecast (2022-2028)

    • 8.4 China Sexually Transmitted Diseases (STDs) Drug Consumption Forecast (2022-2028)

    • 8.5 Japan Sexually Transmitted Diseases (STDs) Drug Consumption Forecast (2022-2028)

    • 8.6 India Sexually Transmitted Diseases (STDs) Drug Consumption Forecast (2022-2028)

    • 8.7 South Korea Sexually Transmitted Diseases (STDs) Drug Consumption Forecast (2022-2028)

    9 Global Sexually Transmitted Diseases (STDs) Drug Market Outlook by Types and Applications to 2022

    • 9.1 Global Sexually Transmitted Diseases (STDs) Drug Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Chlamydia Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Gonorrhea Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Syphilis Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Genital herpes Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global HPV Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global HIV / AIDS Consumption and Growth Rate (2017-2022)

    • 9.2 Global Sexually Transmitted Diseases (STDs) Drug Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Online Pharmacies Consumption and Growth Rate (2017-2022)

    10 Global Sexually Transmitted Diseases (STDs) Drug Market Outlook by Types and Applications to 2028

    • 10.1 Global Sexually Transmitted Diseases (STDs) Drug Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Chlamydia Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Gonorrhea Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Syphilis Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Genital herpes Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global HPV Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global HIV / AIDS Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Sexually Transmitted Diseases (STDs) Drug Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    11 Global Sexually Transmitted Diseases (STDs) Drug Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Sexually Transmitted Diseases (STDs) Drug Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Sexually Transmitted Diseases (STDs) Drug Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Sexually Transmitted Diseases (STDs) Drug Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Sexually Transmitted Diseases (STDs) Drug Market Competitive Analysis

    • 14.1 AbbVie, Inc

      • 14.1.1 AbbVie, Inc Company Details

      • 14.1.2 AbbVie, Inc Sexually Transmitted Diseases (STDs) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 AbbVie, Inc Sexually Transmitted Diseases (STDs) Drug Product and Service

    • 14.2 Bayer Healthcare

      • 14.2.1 Bayer Healthcare Company Details

      • 14.2.2 Bayer Healthcare Sexually Transmitted Diseases (STDs) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Bayer Healthcare Sexually Transmitted Diseases (STDs) Drug Product and Service

    • 14.3 Merck & Co, Inc

      • 14.3.1 Merck & Co, Inc Company Details

      • 14.3.2 Merck & Co, Inc Sexually Transmitted Diseases (STDs) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Merck & Co, Inc Sexually Transmitted Diseases (STDs) Drug Product and Service

    • 14.4 Hoffmann La Roche

      • 14.4.1 Hoffmann La Roche Company Details

      • 14.4.2 Hoffmann La Roche Sexually Transmitted Diseases (STDs) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Hoffmann La Roche Sexually Transmitted Diseases (STDs) Drug Product and Service

    • 14.5 Gilead Sciences

      • 14.5.1 Gilead Sciences Company Details

      • 14.5.2 Gilead Sciences Sexually Transmitted Diseases (STDs) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Gilead Sciences Sexually Transmitted Diseases (STDs) Drug Product and Service

    • 14.6 Pfizer

      • 14.6.1 Pfizer Company Details

      • 14.6.2 Pfizer Sexually Transmitted Diseases (STDs) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Pfizer Sexually Transmitted Diseases (STDs) Drug Product and Service

    • 14.7 GlaxoSmithKline Plc

      • 14.7.1 GlaxoSmithKline Plc Company Details

      • 14.7.2 GlaxoSmithKline Plc Sexually Transmitted Diseases (STDs) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 GlaxoSmithKline Plc Sexually Transmitted Diseases (STDs) Drug Product and Service

    • 14.8 Eli Lilly

      • 14.8.1 Eli Lilly Company Details

      • 14.8.2 Eli Lilly Sexually Transmitted Diseases (STDs) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Eli Lilly Sexually Transmitted Diseases (STDs) Drug Product and Service

    • 14.9 Bristol-Myers Squibb

      • 14.9.1 Bristol-Myers Squibb Company Details

      • 14.9.2 Bristol-Myers Squibb Sexually Transmitted Diseases (STDs) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Bristol-Myers Squibb Sexually Transmitted Diseases (STDs) Drug Product and Service

    • 14.10 Johnson & Johnson

      • 14.10.1 Johnson & Johnson Company Details

      • 14.10.2 Johnson & Johnson Sexually Transmitted Diseases (STDs) Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Johnson & Johnson Sexually Transmitted Diseases (STDs) Drug Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Sexually Transmitted Diseases (STDs) Drug

    • Figure Sexually Transmitted Diseases (STDs) Drug Picture

    • Table Global Sexually Transmitted Diseases (STDs) Drug Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Sexually Transmitted Diseases (STDs) Drug Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Sexually Transmitted Diseases (STDs) Drug Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Sexually Transmitted Diseases (STDs) Drug Consumption by Country (2017-2022)

    • Figure United States Sexually Transmitted Diseases (STDs) Drug Consumption and Growth Rate (2017-2022)

    • Table Europe Sexually Transmitted Diseases (STDs) Drug Consumption and Growth Rate (2017-2022)

    • Figure China Sexually Transmitted Diseases (STDs) Drug Consumption and Growth Rate (2017-2022)

    • Figure Japan Sexually Transmitted Diseases (STDs) Drug Consumption and Growth Rate (2017-2022)

    • Figure India Sexually Transmitted Diseases (STDs) Drug Consumption and Growth Rate (2017-2022)

    • Figure South Korea Sexually Transmitted Diseases (STDs) Drug Consumption and Growth Rate (2017-2022)

    • Figure Global Sexually Transmitted Diseases (STDs) Drug Consumption Forecast by Country (2022-2028)

    • Figure United States Sexually Transmitted Diseases (STDs) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Sexually Transmitted Diseases (STDs) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Sexually Transmitted Diseases (STDs) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Sexually Transmitted Diseases (STDs) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Sexually Transmitted Diseases (STDs) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Sexually Transmitted Diseases (STDs) Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Chlamydia Consumption and Growth Rate (2017-2022)

    • Figure Global Gonorrhea Consumption and Growth Rate (2017-2022)

    • Figure Global Syphilis Consumption and Growth Rate (2017-2022)

    • Figure Global Genital herpes Consumption and Growth Rate (2017-2022)

    • Figure Global HPV Consumption and Growth Rate (2017-2022)

    • Figure Global HIV / AIDS Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Online Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Chlamydia Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Gonorrhea Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Syphilis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Genital herpes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global HPV Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global HIV / AIDS Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Sexually Transmitted Diseases (STDs) Drug Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Sexually Transmitted Diseases (STDs) Drug Export by Region (Top 5 Countries) (2017-2028)

    • Table AbbVie, Inc (Foundation Year, Company Profile and etc.)

    • Table AbbVie, Inc Sexually Transmitted Diseases (STDs) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbbVie, Inc Sexually Transmitted Diseases (STDs) Drug Product and Service

    • Table Bayer Healthcare (Foundation Year, Company Profile and etc.)

    • Table Bayer Healthcare Sexually Transmitted Diseases (STDs) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Healthcare Sexually Transmitted Diseases (STDs) Drug Product and Service

    • Table Merck & Co, Inc (Foundation Year, Company Profile and etc.)

    • Table Merck & Co, Inc Sexually Transmitted Diseases (STDs) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck & Co, Inc Sexually Transmitted Diseases (STDs) Drug Product and Service

    • Table Hoffmann La Roche (Foundation Year, Company Profile and etc.)

    • Table Hoffmann La Roche Sexually Transmitted Diseases (STDs) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hoffmann La Roche Sexually Transmitted Diseases (STDs) Drug Product and Service

    • Table Gilead Sciences (Foundation Year, Company Profile and etc.)

    • Table Gilead Sciences Sexually Transmitted Diseases (STDs) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Gilead Sciences Sexually Transmitted Diseases (STDs) Drug Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Sexually Transmitted Diseases (STDs) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Sexually Transmitted Diseases (STDs) Drug Product and Service

    • Table GlaxoSmithKline Plc (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Plc Sexually Transmitted Diseases (STDs) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Plc Sexually Transmitted Diseases (STDs) Drug Product and Service

    • Table Eli Lilly (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly Sexually Transmitted Diseases (STDs) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly Sexually Transmitted Diseases (STDs) Drug Product and Service

    • Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Squibb Sexually Transmitted Diseases (STDs) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb Sexually Transmitted Diseases (STDs) Drug Product and Service

    • Table Johnson & Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson Sexually Transmitted Diseases (STDs) Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Sexually Transmitted Diseases (STDs) Drug Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US